193 related articles for article (PubMed ID: 15627648)
1. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
Chen HH; Lainchbury JG; Harty GJ; Burnett JC
Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
[TBL] [Abstract][Full Text] [Related]
4. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
[TBL] [Abstract][Full Text] [Related]
5. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
6. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
7. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
[TBL] [Abstract][Full Text] [Related]
8. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
[TBL] [Abstract][Full Text] [Related]
9. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
11. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
[TBL] [Abstract][Full Text] [Related]
12. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
[TBL] [Abstract][Full Text] [Related]
13. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
15. CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.
Chen Y; Harty GJ; Huntley BK; Iyer SR; Heublein DM; Harders GE; Meems L; Pan S; Sangaralingham SJ; Ichiki T; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R407-R414. PubMed ID: 29187381
[TBL] [Abstract][Full Text] [Related]
16. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
17. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
19. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.
Lainchbury JG; Burnett JC; Meyer D; Redfield MM
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H33-40. PubMed ID: 10644581
[TBL] [Abstract][Full Text] [Related]
20. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
